Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells. The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States.
Monoclonal Antibody Targets, Kills Leukemia Cells
Source: UC San Diego
Art and Science of Laboratory Medicine
Web site: laboratoryeqas.exai.com